Medicine and Dentistry
Adaptive Clinical Trial
10%
Biopsy Technique
10%
Cancer Inhibition
10%
Clinical Trial
10%
Combination Therapy
100%
Diseases
30%
First-in-Man Study
10%
Hope
10%
In Vitro
10%
Kinase
10%
Macrophage
100%
Malignant Peripheral Nerve Sheath Tumor
100%
Mammalian Target of Rapamycin Inhibitor
10%
Neoplasm
100%
Orphan Drug
10%
Pexidartinib
100%
Phosphotransferase
10%
Phosphotransferase Inhibitor
10%
Rapamycin
100%
Tumor Xenograft
10%
Pharmacology, Toxicology and Pharmaceutical Science
Adaptive Clinical Trial
9%
Cancer Inhibition
9%
Chemotherapy
9%
Clinical Trial
9%
Combination Therapy
100%
Diseases
27%
Malignant Peripheral Nerve Sheath Tumor
100%
Mammalian Target of Rapamycin Inhibitor
9%
Neoplasm
100%
Orphan Drug
9%
Pexidartinib
100%
Phosphotransferase
9%
Phosphotransferase Inhibitor
9%
Rapamycin
100%
Biochemistry, Genetics and Molecular Biology
Adaptive Clinical Trial
25%
Clinical Trial
25%
Growth Inhibition
25%
Hope
25%
Kinase
50%
Macrophage
100%
Mechanistic Target of Rapamycin
25%
Phosphotransferase
50%
Tumor Progression
25%
Tumor-Associated Macrophage
100%